Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307).
Fiche publication
Date publication
janvier 2015
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme, Pr QUANTIN Catherine, Dr DEVILLIERS Hervé
Tous les auteurs :
Nuemi G, Devilliers H, Le Malicot K, Guimbaud R, Lepage C, Quantin C
Lien Pubmed
Résumé
OBJECTIVE: Quality of life data in cancerology are often difficult to summarize due to missing data and difficulty to analyze the pattern of evolution in different groups of patients. The aim of this work was to apply a new methodology to construct Quality of Life (QoL) change patterns within patients included in a clinical trial comparing to regimen of treatment in locally advanced eosogastric cancer. MATERIALS AND METHODS: In this trial, QoL was assessed every 2 months by self-reported EORTC QLQ-C30 questionnaire. Physical dimension scores were analyzed. After multiple imputation of missing data, 27 statistical measures aiming to describe the variation of QoL measures among follow-up were computed for each patient. Based on these measures, patient were grouped into homogenous groups in terms of QoL variation pattern using a K-Means classification method. The mean QoL score at each time was graphically represented in each obtained pattern. Finally, clinical characteristic of patients in each pattern of QoL were described and compared. RESULTS: The trial included 416 patients and 1023 questionnaire were collected. 74 % of patients were male with a mean +/- SD age of 62 +/- 11 years. 43 % of scores were missing. Patients were grouped into four classes of homogeneous QoL variation patterns. 1) a Pattern of 24 (6 %) patients showing improvement in QoL with a mean variation of +10.7 points on the 0-100 scale, 2) a Pattern of 171 (41 %) patients showing a stability 3) two Patterns of 78 (19 %) and 143 (34 %) patients respectively showing a deterioration of QoL with a mean variation of -67.2 and -67.6, respectively. There were no difference between patterns in terms of gender or age. Patients within "degradation" pattern had significantly lower performance status (p = 0.015), higher severe after-effects rate (p < 10-3) and death rate (p < 10-3). CONCLUSION: This work opens up perspectives for longitudinal data analysis with a high probability of missing values while providing a relevant graphical summary. Patterns of QoL evolution with clinical relevance may help to interpret longitudinal QoL data in Cancer studies.
Référence
Health Qual Life Outcomes. 2015 Sep 22;13(1):151.